Get started
Author

Umut Kefeli

Observed names: KEFELİ, UMUT, KEFELİ, Umut, Kefeli, U., Kefeli, UMUT, Kefeli, Umut, Kefeli,Umut, U Kefeli, U. KEFELI, U. Kefeli, UMUT KEFELI, Umut KEFELİ, Umut Kefelı, Umut, Kefeli
ORCID: 0000-0001-6126-5377
Observed ORCID: 0000-0001-6126-5377
OpenAlex ID: A5028866830
Hepatogastroenterology
2011 · Mesut Seker, Ahmet Bilici, et al. · Hepatogastroenterology · 313
Prognostic Significance of Perineural Invasion in Patients with Gastric Cancer Who Underwent Curative Resection
2010 · Ahmet Bilici, Mesut Seker, et al. · Annals of Surgical Oncology · 110
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial
2023 · A.O. Siefker-Radtke, N. Matsubara, et al. · Annals of Oncology · 102
PDF
Netrin-1 in cancer: Potential biomarker and therapeutic target?
2017 · Umut Kefeli, Aysegul Ucuncu Kefeli, et al. · Tumor Biology · 54
PDF
The role of 18F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients’ treatment decision making?
2010 · Ahmet Bilici, Bala Basak Oven Ustaalioglu, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 52
Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer
2009 · U. KEFELI, F. DANE, et al. · European Journal of Cancer Care · 48
PDF
The Importance of Multifocal/Multicentric Tumor on the Disease-Free Survival of Breast Cancer Patients: Single Center Experience
2011 · Basak Oven Ustaalioglu, Ahmet Bilici, et al. · American Journal of Clinical Oncology · 43
The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligand therapy in metastatic castration‐resistant prostate cancer: Turkish Oncology Group multicenter study
2023 · Elvina Almuradova, Mustafa Seyyar, et al. · International Journal of Cancer · 35
Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value in metastatic castration-resistant prostate cancer patients who underwent 177Lu–PSMA-617
2023 · Elif Şahin, Umut Kefeli, et al. · Medicine · 30
Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma
2016 · Dincer Aydin, Mehmet Ali Sendur, et al. · Clinical Colorectal Cancer · 28
Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment
2012 · Umut Kefeli, Mahmut Emre Yildirim, et al. · Biomarkers · 27
Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection
2016 · Dincer Aydin, Mehmet Ali Sendur, et al. · Clinical Colorectal Cancer · 26
Is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?
2010 · Ahmet Bilici, Bala B.O. Ustaalioglu, et al. · Oncology Research and Treatment · 24
The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker
2016 · Mahmut Emre Yıldırım, Umut Kefeli, et al. · Tumor Biology · 23
Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
2015 · D. Aydin, A. Bilici, et al. · Clinical & Translational Oncology · 23
Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis
2012 · T. Korkmaz, S. Seber, et al. · Clinical & Translational Oncology · 20
Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).
2016 · Dincer Aydin, Mehmet Ali Sendur, et al. · PubMed · 18
Prognostic Factors for Operated Gallbladder Cancer
2018 · Bala Basak Oven Ustaalioglu, Ahmet Bilici, et al. · Journal of Gastrointestinal Cancer · 17
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience
2013 · UMUT KEFELI, MUSTAFA BENEKLI, et al. · Oncology Letters · 17
PDF
Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience
2010 · U. Kefeli, S. Kaya, et al. · Medical Oncology · 15
Perceptions and acceptance of telemedicine among medical oncologists before and during the COVID-19 pandemic in Turkey
2021 · Elif Sahin, Umut Kefeli, et al. · Supportive Care in Cancer · 13
PDF
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
2023 · Çağlar Ünal, Abdulmunir Azizy, et al. · The Oncologist · 11
PDF
Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences
2010 · Bala Basak Oven Ustaalioglu, Ahmet Bilici, et al. · Oncology · 11
Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer.
2014 · Bala Basak Oven Ustaalioglu, Fugen Aker Vardar, et al. · PubMed · 9
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
2012 · Mehmet Eser, Metin Kement, et al. · World Journal of Surgical Oncology · 9
PDF
Works count: 164
Citation count: 1,207
H-index: 17
I10-index: 23
Year
Topic
Type